Open AccessOxaliplatin/5-Fluorouracil/Leucovorin (FOLFOX4) Regimen as an Adjuvant Chemotherapy in the Treatment of Advanced Jejunal Adenocarcinoma: A Report of 2 Cases
Author(s) -
ChaoWen Chen,
WenMing Wang,
Yu-Chung Su,
JengYih Wu,
JanSing Hsieh,
JawYuan Wang
Publication year - 2008
Publication title -
medical principles and practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.426
H-Index - 45
eISSN - 1423-0151
pISSN - 1011-7571
DOI - 10.1159/000151574
Subject(s) - medicine , oxaliplatin , fluorouracil , regimen , chemotherapy , oncology , adjuvant , adjuvant chemotherapy , gastroenterology , adenocarcinoma , colorectal cancer , cancer , breast cancer
To present our clinical experience of 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen administered as an adjuvant chemotherapy to 2 patients with advanced jejunal adenocarcinoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom